Weight change and clinical outcomes in heart failure with reduced ejection fraction: Insights from EMPEROR-Reduced (vol 25, pg 117, 2023)

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷 / 06期
关键词：
D O I：
10.1002/ejhf.2910
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：924 / 924
页数：1
相关论文
共 50 条
  • [1] Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced
    Anker, Stefan D.
    Khan, Muhammad Shahzeb
    Butler, Javed
    Ofstad, Anne Pernille
    Peil, Barbara
    Pfarr, Egon
    Doehner, Wolfram
    Sattar, Naveed
    Coats, Andrew J. S.
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Zannad, Faiez
    Pocock, Stuart
    Packer, Milton
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (01) : 117 - 127
  • [2] Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction The EMPEROR-Reduced Trial
    Packer, Milton
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Carson, Peter
    Anand, Inder
    Doehner, Wolfram
    Haass, Markus
    Komajda, Michel
    Miller, Alan
    Pehrson, Steen
    Teerlink, John R.
    Brueckmann, Martina
    Jamal, Waheed
    Zeller, Cordula
    Schnaidt, Sven
    Zannad, Faiez
    [J]. CIRCULATION, 2021, 143 (04) : 326 - 336
  • [3] Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial (vol 143, pg 326, 2021)
    Packer
    [J]. CIRCULATION, 2021, 143 (04) : E30 - E30
  • [4] Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced
    Ferreira, Joao Pedro
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Iwata, Tomoko
    Salsali, Afshin
    Zeller, Cordula
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (04) : 708 - 715
  • [5] EMPEROR-Reduced supports the use of SGLT2 inhibitors for the treatment of patients with heart failure and reduced ejection fraction: Comment on the EMPEROR-Reduced trial
    Liuzzo, Giovanna
    Patrono, Carlo
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (40) : 3881 - 3882
  • [6] Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced
    Filippatos, Gerasimos
    Anker, Stefan D.
    Butler, Javed
    Farmakis, Dimitrios
    Ferreira, Joao Pedro
    Gollop, Nicholas D.
    Brueckmann, Martina
    Iwata, Tomoko
    Pocock, Stuart
    Zannad, Faiez
    Packer, Milton
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2297 - 2304
  • [7] Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
    Butler, Javed
    Anker, Stefan D.
    Filippatos, Gerasimos
    Khan, Muhammad Shahzeb
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Giannetti, Nadia
    Januzzi, James L.
    Pina, Ileana L.
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Sattar, Naveed
    Verma, Subodh
    Brueckmann, Martina
    Jamal, Waheed
    Vedin, Ola
    Peil, Barbara
    Zeller, Cordula
    Zannad, Faiez
    Packer, Milton
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (13) : 1203 - 1212
  • [8] Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
    Lam, Carolyn S. P.
    Ferreira, Joao Pedro
    Pfarr, Egon
    Sim, David
    Tsutsui, Hiroyuki
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Pocock, Stuart J.
    Sattar, Naveed
    Verma, Subodh
    Brueckmann, Martina
    Schnee, Janet
    Cotton, Daniel
    Zannad, Faiez
    Packer, Milton
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (43) : 4442 - 4451
  • [9] Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial
    Khan, Muhammad Shahzeb
    Anker, Stefan D.
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Januzzi, James L.
    Chopra, Vijay K.
    Pina, Ileana L.
    Boehm, Michael
    Ponikowski, Piotr
    Verma, Subodh
    Brueckmann, Martina
    Vedin, Ola
    Peil, Barbara
    Zannad, Faiez
    Packer, Milton
    Butler, Javed
    [J]. JOURNAL OF CARDIAC FAILURE, 2023, 29 (10) : 1345 - 1354
  • [10] Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial
    Tsutsui, Hiroyuki
    Sakamaki, Hiroyuki
    Momomura, Shin-ichi
    Sakata, Yasushi
    Kotobuki, Yutaro
    Linden, Stephan
    Reifsnider, Odette S.
    Rakonczai, Pal
    Stargardter, Matthew
    Murata, Tatsunori
    Hirase, Tetsuaki
    Nitta, Daisuke
    [J]. JOURNAL OF CARDIOLOGY, 2023, 81 (06) : 522 - 530
12345